Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56

(2020) Rie Sakakibara et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers: A Comprehensive Study and Review of the Literature

(2020) Johan Staaf et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Insulinoma‐associated protein 1 is a prognostic biomarker in pulmonary high‐grade neuroendocrine carcinoma

(2020) Kazuhiro Minami et al.   JOURNAL OF SURGICAL ONCOLOGY

Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer

(2019) Katharina Kriegsmann et al.   PATHOLOGY

Spatial and temporal heterogeneity of panel-based tumor mutational burden (TMB) in pulmonary adenocarcinoma: separating biology from technical artifacts

(2019) Daniel Kazdal et al.   Journal of Thoracic Oncology

INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors

(2018) Lisa M. Rooper et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples

(2018) Alice Ly et al.   Proteomics Clinical Applications

Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56

(2018) Katharina Kriegsmann et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

(2018) Yasushi Yatabe et al.   Journal of Thoracic Oncology

Correlation of neuroendocrine features with prognosis of non-small cell lung cancer

(2016) Jianguo Feng et al.   Oncotarget

Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases

(2015) Mark Kriegsmann et al.   Diagnostic Pathology

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype

(2013) A. Warth et al.   EUROPEAN RESPIRATORY JOURNAL

Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies

(2012) Arne Warth et al.   HISTOPATHOLOGY

Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

(2012) Dariusz M. Kowalski et al.   RESPIRATION

Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer

(2011) Marina Petrović et al.   BIOMARKERS

Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases

(2009) William Sterlacci et al.   VIRCHOWS ARCHIV